VKTX - Viking Therapeutics, Inc.
32.98
1.470 4.457%
Share volume: 2,947,342
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$31.51
1.47
0.05%
Summary score
21%
Profitability
25%
Dept financing
2%
Liquidity
50%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2016 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-33.18%
Return on assets
-11.96%
Return on sales
0%
Return on invested capital
110.6%
Total debt ratio
18.88%
Debt ratio change over timeo
0%
Current Ratio
30.1%
Quick Ratio
0%
Cash Position Ratio
4.73%
Short-term ratios 30-Sep-2019 - 30-Sep-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-3.4%
Return on assets
-3.68%
Return on sales
0%
Return on invested capital
115.06%
Total debt ratio
3.21%
Debt ratio change over timeo
0%
Current Ratio
32.79%
Quick Ratio
0%
Cash Position Ratio
1.37%
Last quarter ratios 30-Sep-2020
The data are presented for the financials results of the last quarter.
Return on equity
-3.66%
Return on assets
-3.73%
Return on sales
0%
Return on invested capital
100.67%
Total debt ratio
3.73%
Debt ratio change over time
0%
Current Ratio
27.09%
Quick Ratio
0%
Cash Position Ratio
0.4%
Performance ratios (change over 4 years) 30-Sep-2016 - 30-Sep-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | VKTX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -33.18% | 18.71% | 4.67% | -3.65% |
| Return on assets | -11.96% | 3.4% | 3.32% | 3.5% |
| Return on sales | 0% | 24.27% | 25.81% | 31.31% |
| Return on invested capital | 110.6% | 5.38% | 4.17% | 4.99% |
| Profitability | 25% | 70% | 52% | 51% |
| Total debt ratio | 18.88% | 78.91% | 58.54% | 101.15% |
| Debt ratio change over time | 0% | 0% | 10.69% | 52.18% |
| Dept financing | 5% | 20% | 20% | 50% |
| Current Ratio | 32.79% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 0% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 1.37% | 0.21% | 0.6% | 1.41% |
| Liquididy | 50% | 22% | 29% | 30% |
| Short-term ratios | VKTX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -3.4% | 41.05% | 6.87% | -16.17% |
| Return on assets | -3.68% | 3.67% | 3.13% | 2.71% |
| Return on sales | 0% | 26.16% | 24.75% | 29.9% |
| Return on invested capital | 115.06% | 9.43% | 5.58% | 6.54% |
| Profitability | 25% | 74% | 47% | 45% |
| Total debt ratio | 3.21% | 91.28% | 61.3% | 99.31% |
| Debt ratio change over time | 0% | 0% | 13.89% | -24.55% |
| Dept financing | 1% | 23% | 40% | 25% |
| Current Ratio | 32.79% | 1.21% | 1.33% | 2.03% |
| Quick Ratio | 0% | 0.94% | 1.07% | 1.9% |
| Cash Position Ratio | 1.37% | 0.21% | 0.6% | 1.41% |
| Liquididy | 49% | 17% | 26% | 52% |